Posted on 04 May 2011
Tags: big pharma, Cephalon, M&A, Teva
Teva states in a notice to the US Securities and Exchange Commission (SEC) that if Cephalon cancels its acquisition by Teva, it will pay a fine of 4% of the $6.8 billion deal - or $275 million.
See the Teva/Cephalon contract and deal data
Click here to cancel reply.
Email (will not be published) (required)
Your website (optional)
© 2020 Wildwood Ventures Ltd.